Now Is The Time To Use An Interactive Flow Diagram To Tell Patient Narratives

Background The digital evolution of the pharmaceutical industry has made it easier to track various aspects of a patient’s journey and represent complex data with interactive and understandable flow diagrams. Rather than simply plotting possible pathways, these intelligent diagrams and graphs enable healthcare practitioners and researchers to explore and analyze hidden relationships and receive instant […]

Senior Associate, HEOR 8

Over six years of experience in the HEOR/RWE space with proven expertise in RWE studies using SAS based on claims, EMR, and registry data. Rich background in categorical data analysis, survival analysis, randomized trial designs analysis, macro definitions, debugging programs, and documentation in both SAS and R programming environments. Expert in Advanced Excel/VBA including mastery […]

Looking Ahead in Oncology

WHAT WILL YOU LEARN KOL Panel Discusses Cell and Gene Therapy Trends Join Lisa Logan and a group of oncology experts in discussing the possibilities of CAR T-cell therapy expansion to treat solid tumors as well as the implications on the current and future landscape of treatments across tumor types. Get this content Emailed

Migraine Study Demonstrates Impact of Treatment Failures on Healthcare System

Summary: The economic burden caused by treatment failures of migraine was explored in a study led by Dr. Lujia Zhou, KMK Consulting, Inc. The study results, published in The Journal of Neurology, “Economic Burden Increased with Number of Treatment Failures in Migraine Patients -A Retrospective Claims Database Analysis in the United States (1485),”demonstrated clearly that […]

How to become the Iron Man of Data Analytics?

Do you feel sluggish or lethargic most days? Are you susceptible to catching colds? If you blame the “daily grind” for why you’re feeling rundown, you might be overlooking a simple nutrient deficiency. Iron is needed to make hemoglobin — part of our red blood cells that carries oxygen to the body’s tissues. In addition, […]

Exploring the significance of Real World Evidence and Real World Data

The terms Real World Evidence (RWE) and Real World Data (RWD) appear more and more in industry discussions and within FDA reports. The pharma industry is embracing RWE and it is quickly becoming the next big thing in industry intelligence. FDA guidelines have been published for using RWE in clinical studies and the FDA is […]

HEOR Principal Huanxue Zhou’s Manuscript in BURNS Journal

KMK HEOR Principal Huanxue Zhou‘s latest manuscript: Healthcare resource utilization, treatment patterns, and cost of care among patients with thermal burns and inpatient autografting in two large privately insured populations in the United States. Highlights • Major economic burdens exist for thermal burn injury with inpatient autografting.• This cost burden is mainly driven by initial hospitalization with autografting.• Resource […]

Smarter Real World Evidence: A Flexible Client-Centered Dashboard Can Help Data Tell a Better Story

If analyzed correctly, compelling data can serve business needs and reveal commercial opportunities. The KMK Real World Evidence Dashboard is a customized client-centered approach to help biopharmaceutical companies reach intuitive conclusions faster, save significant time on re-analysis, and improve recall and comprehension with a clean graphical approach to sharing the story inherent in the data. […]

HEOR Principal Huanxue Zhou’s Manuscript in International Journal of MS Care

KMK HEOR Principal Huanxue Zhou‘s latest manuscript, Impact of Switching to Fingolimod Versus Injectable Disease-Modifying Therapy Cycling on Risk of Multiple Sclerosis-Related Relapses, was published in the International Journal of MS Care. A PDF of the article is available for download. BACKGROUND Clinical and real-world studies have shown significant reductions in MS relapses in patients receiving fingolimod versus […]